Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: DiaMedica Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
INVE Technologies Inc. September 10, 202664.2%
-
INVE Technologies Inc. June 28, 202487.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 30, 2026 | INVE Technologies Inc. | Grant or award | +17,544 | — | — |
| Jul 29, 2025 | INVE Technologies Inc. | Grant or award | +21,148 | — | — |
| Jan 2, 2025 | DiaMedica Therapeutics Inc. | Grant or award | +9,925 | $5.34 | $53,000 |
| Jul 29, 2024 | INVE Technologies Inc. | Grant or award | +14,773 | — | — |
| Jan 2, 2024 | DiaMedica Therapeutics Inc. | Grant or award | +14,285 | $2.80 | $39,998 |
| Aug 1, 2023 | INVE Technologies Inc. | Grant or award | +8,904 | — | — |
Questions about Richard Kuntz
What boards is Richard Kuntz on?
Richard Kuntz sits on the boards of DiaMedica Therapeutics Inc. and INVE Technologies Inc.
How long has Richard Kuntz served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.